Pharma & life sciences | Modelled case study
Prioritize harvest-now-decrypt-later risk in drug-discovery data
Which target, compound, genomic, and partnership datasets retain economic value past current encryption assumptions?
The modelled organisation
A recognisable problem reaches the operating agenda
This composite scenario follows the Research CISO · Intellectual Property Counsel · Data Platform functions. It is grounded in the cited problem context but does not identify a real customer.
Operating environment
A life-sciences organisation moves regulated and commercially sensitive data through instruments, laboratories, research partners, trial platforms, archives, and submissions.
What is at stake
Loss of provenance or long-term confidentiality can undermine a study, expose valuable research, delay a submission, or make a regulated record indefensible.
Situation
Research repositories are classified by project secrecy but rarely by confidentiality horizon and the cryptography protecting transfers, notebooks, backups, and partner exchanges.
Event that forces action
A strategic research partnership, data-lake consolidation, or quantum-readiness programme.
Concrete system boundary
Systems this case study puts in scope
The model is specific about the operational surfaces that must be discovered, changed, or independently checked.
target and compound datasets
genomic and assay data
partner transfer channels
research archives and backups
Modelled case study walkthrough
How this organisation would use QNSI
The walkthrough connects the real-world problem to a bounded QNSI contribution and an independently reviewable result.
Recognise the operating condition
Research repositories are classified by project secrecy but rarely by confidentiality horizon and the cryptography protecting transfers, notebooks, backups, and partner exchanges.
Frame the decision the owners must make
Which target, compound, genomic, and partnership datasets retain economic value past current encryption assumptions?
Apply QNSI to the controlled boundary
Join QNSI crypto discovery with data owners, patent milestones, collaboration paths, and sensitivity duration.
Leave the team with a concrete result
An R&D quantum-exposure portfolio ranking datasets by value horizon, capture surface, and remediation option.
Prove the result in the organisation's environment
Research and legal owners decide data value, export controls, collaboration constraints, and acceptable re-protection methods.
What useful success looks like
A decision artifact plus proof from the real environment
The model stops at a target result. It becomes an actual case study only when a customer produces and independently validates this evidence in production.
Decision artifact
An R&D quantum-exposure portfolio ranking datasets by value horizon, capture surface, and remediation option.
Independent validation boundary
Research and legal owners decide data value, export controls, collaboration constraints, and acceptable re-protection methods.
Real-world problem grounding
Primary sources behind the model
These sources establish the external requirement, failure mode, or risk context used to model this case. They do not endorse HEOSSI or prove that QNSI completed the scenario.
Customer evidence status
This is modelled, not a customer claim
The organisation is a composite and the result is a target state. This page does not prove a deployment, customer outcome, certification, legal conclusion, regulator endorsement, or completed control.